Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2) - Wikidata - wikimedia - TriplyDB

Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

http://www.wikidata.org/entity/Q37295343

about

An empirical investigation of the potential impact of selective inclusion of results in systematic reviews of interventions: study protocol Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study.Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.Hip fracture evaluation with alternatives of total hip arthroplasty versus hemiarthroplasty (HEALTH): protocol for a multicentre randomised trial A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol StaR Child Health: developing evidence-based guidance for the design, conduct and reporting of paediatric trials.Presentation approaches for enhancing interpretability of patient-reported outcomes (PROs) in meta-analysis: a protocol for a systematic survey of Cochrane reviews Monitoring in clinical trials: benefit or bias?StaR Child Health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials.Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial.Femoroacetabular Impingement Randomised controlled Trial (FIRST) - a multi-centre randomized controlled trial comparing arthroscopic lavage and arthroscopic osteochondroplasty on patient important outcomes and quality of life in the treatment of youn

P2860

Q24633869-3AB0EA65-2424-4A5A-9B75-AC2A64ADD15D Q30871934-747E973C-B59A-4253-994A-D46F5B82A37F Q30878095-A5ABBB10-F120-429B-9CE0-4E233F110F27 Q35088905-39E60B06-2441-4475-8996-49D02AF9F3AE Q38170584-46C6CC73-EC4A-465C-9D17-D09A00AAC384 Q38254720-EC24F262-437F-49D2-A673-7C8B8552FFFA Q42172726-BF882FC2-18A4-4168-B493-3B74C0E72C8F Q44902803-5F3C1353-A18E-4B89-85B7-34833D45DB3E Q53143992-AA559717-CCF0-4DE6-BF34-522B5BC48801 Q55499573-400A0F27-ECE7-46A6-9D49-589B2F0C515F Q58107806-04723871-6EDB-4672-A3A8-CF2CBC7EDAE8

P2860

Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

http://www.wikidata.org/entity/Q37295343

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stopping randomized trials ear ...... nterim Truncation-2 (STOPIT-2)

@en

Stopping randomized trials ear ...... Policy Of Interim Truncation-2

@nl

type

label

Stopping randomized trials ear ...... nterim Truncation-2 (STOPIT-2)

@en

Stopping randomized trials ear ...... Policy Of Interim Truncation-2

@nl

prefLabel

Stopping randomized trials ear ...... nterim Truncation-2 (STOPIT-2)

@en

Stopping randomized trials ear ...... Policy Of Interim Truncation-2

@nl

P1433

Q37295343-CE013308-8064-4ED5-A616-D0D5B799B33F

P1476

Q37295343-03FB9F9D-82A0-4A99-875B-5EC6F04EA615

P2093

Q37295343-04A75DA5-D797-47C0-B4C8-9CA7D7D043A4

Q37295343-0A5941D5-E0E3-45CE-ACE4-BC0848BB98D6

Q37295343-0F85C8AE-7337-4327-8FE8-931BF680AFB3

Q37295343-115A048C-C4AC-44B5-823C-ADA79D164689

Q37295343-12BB3AF8-6543-42BA-9677-F0B4C2C496DC

Q37295343-156C7985-B224-47D1-91C8-DF9332292C84

Q37295343-18763B17-54B3-4E6D-81D9-47FEAB2DE24D

Q37295343-1AF8F17B-134D-4796-BDD0-DA77CC5B1BD3

Q37295343-1FB7544D-1A39-4136-9520-55EFFA83A4FD

Q37295343-243A322F-51C6-4220-8D56-DD37D0EA448A

P2860

Q37295343-1695CAD2-E86C-4234-ABF1-87ED5114934B

Q37295343-1BEE9945-546F-4D7D-AB74-B81D439F95A5

Q37295343-2135FEF3-0D3B-4192-8126-B19C219A0C72

Q37295343-27DABD02-A390-4644-B80B-67447C3B6F14

Q37295343-44AEEA2D-0322-4102-A9C5-B40D08DC8389

Q37295343-494E8071-C7EE-4457-9C57-19D0FD62A620

Q37295343-4BB00954-3FBD-4429-85C7-D71301306336

Q37295343-4E9BF78D-FC7F-4A77-BC8D-F7BF6DCBE5A9

Q37295343-5DDB8578-A832-4453-A29F-755B352544DD

Q37295343-7DD4F54A-34CE-4831-AC70-B3F04DC4D17B

P2888

Q37295343-1C119EE7-B318-4BE6-9E31-D68DC57AF461

P304

Q37295343-A4BDDEF3-E031-471F-AE07-F822FC09B67C

P31

Q37295343-6357451B-75A3-495B-8892-1BBAA2538993

P356

Q37295343-47848C07-20AB-4616-B4E6-5ED0AAF948F7

P478

Q37295343-741B1BCA-0F14-4223-BAB6-112A6A6AFEE2

P50

Q37295343-094E9D80-0D33-4D4A-B465-94B0128D009A

Q37295343-09C01621-BE07-4A84-A6B6-5513D7DCFC7F

Q37295343-5D2B2979-1C13-4D34-8D35-BDEE1D518FFA

Q37295343-6C192B4F-3703-4D00-800B-D83A641BB61E

Q37295343-77311BB1-D2DD-448F-A979-647C996BA90A

Q37295343-7970602B-9C25-4E2B-A060-9C79017922CD

Q37295343-8708A2B6-B159-4B5C-A1A8-82A7C52ACE8C

Q37295343-C1F75D0B-7D8F-4511-B7D2-3B637A859BB7

Q37295343-D5DE4D4E-45C5-4491-AE74-BED8DDB02E1B

Q37295343-DAC1003E-0258-442A-A08F-63BDBC9FB23A

P577

Q37295343-B4BBBEDD-11CD-4DFE-B19D-95FD18942749

P5875

Q37295343-379A4B6E-7ECC-45AA-80F6-7F5CC52492FF

P698

Q37295343-D9682C8A-C0D8-40CE-B8D1-B1CFBE8060B1

P932

Q37295343-C9D7E0F9-4441-4C82-A2B1-885B77CD30BD

P356

1745-6215-10-49

P1433

P1476

Stopping randomized trials ear ...... nterim Truncation-2 (STOPIT-2)

@en

P2093

Alain J Nordmann

http://www.w3.org/2001/XMLSchema#string

Amit Sood

http://www.w3.org/2001/XMLSchema#string

Brigitte Strahm

http://www.w3.org/2001/XMLSchema#string

Carolina Ruiz Culebro

http://www.w3.org/2001/XMLSchema#string

Christine M Ribic

http://www.w3.org/2001/XMLSchema#string

Clare R Bankhead

http://www.w3.org/2001/XMLSchema#string

David N Flynn

http://www.w3.org/2001/XMLSchema#string

Deborah J Cook

http://www.w3.org/2001/XMLSchema#string

Diane Heels-Ansdell

http://www.w3.org/2001/XMLSchema#string

Dirk Bassler

http://www.w3.org/2001/XMLSchema#string

P2860

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Optimal search strategies for retrieving systematic reviews from Medline: analytical survey

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.

Stopping at nothing? Some dilemmas of data monitoring in clinical trials.

Systematic reviewers neglect bias that results from trials stopped early for benefit.

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Multiplicity in randomised trials II: subgroup and interim analyses.

P2888

1745-6215-10-49

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1745-6215-10-49

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Djulbegovic

Pablo Alonso-Coello

Paul P. Glasziou

Diane Heels-Ansdell

Per Olav Vandvik

P577

2009-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45072815

http://www.w3.org/2001/XMLSchema#string

P698

19580665

http://www.w3.org/2001/XMLSchema#string

P932

2723099

http://www.w3.org/2001/XMLSchema#string